The size of the Hemodynamic Monitoring Systems Market worth in Europe was valued at USD 269.81 Million in 2020. It is projected to reach USD 331.93 Million by 2025, growing at a CAGR of 4.23% during the forecast period.
The hemodynamic monitoring system is primarily used for clinical inspection of cardiovascular health, longevity, and quality of life of patients undergoing and recovering from cardiac surgery. Physicians perform hemodynamic monitoring using a pulmonary artery catheter that helps administer and maintain adequate perfusion pressure. It helps to identify these risk factors and improve clinical status.
The growing aging population, rising demand for home-based and non-invasive monitoring systems are majorly driving the European regional market. Y-O-Y growth in cardiac disorders incidence is another factor significantly fuelling the market during the forecast period. As per the statistics published by the European Heart Network, every year, around 3.9 million people are dying through CVDs in Europe. An increasing number of hospitals equipping with hemodynamic monitoring tools is also delivering a healthy boost to the growth rate of the market. Extensive usage of these systems in applications like home healthcare, clinics, hospitals, and ambulatory surgery centers contributes to market growth.
The high costs associated with these devices is one of the prime factors restraining the market. Side effects like bleeding, thrombosis, hemorrhage, and sepsis-related with invasive hemodynamic monitoring is expected to hamper the market growth to a small extent.
This research report on the Europe Hemodynamic Monitoring Systems Market has been segmented and sub-segmented into the following categories:
Based on the region, Europe is the second biggest market globally in terms of market share. Increasing competition and market maturity in this region have reduced the scope of expansion. Numerous awareness programs organized by the European Heart Health Charter is helping the market to thrive further.
The UK market is predicted to lead the European market during the forecast period. The percentage of the aging population diagnosed with various diseases is comparatively high in the United Kingdom than in other European countries.
Germany was accounted for the second-largest share in the European market in 2019. The growing demand for these devices and the ever-increasing number of surgeries happening in this country drive market growth.
Top Companies leading the Europe Hemodynamic Monitoring Systems Market profiled in the report are Edwards Lifesciences Corporation, PULSION Medical Systems SE, LiDCO Group plc., Cheetah Medical Inc., Deltex Medical Group plc., Hemo Sapiens, Inc., ICU Medical, Inc., Osypka Medical GmbH, Schwarzer Cardiotek GmbH, and Tensys Medical, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product Type
5.1.2 Hemodymanic monitoring systems
18.104.22.168 Pulmonary artery catheters
22.214.171.124 Cardiac output monitoring system
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Monitoring Type
5.2.2 Invasive hemodynamic monitoring system
5.2.3 Minimally invasive hemodynamic monitoring system
5.2.4 Non-invasive hemodynamic monitoring system
5.2.5 Y-o-Y Growth Analysis, By Monitoring Type
5.2.6 Market Attractiveness Analysis,By Monitoring Type
5.2.7 Market Share Analysis, By Monitoring Type
5.3 End Users
5.3.3 Catheterization laboratories
5.3.4 Home and Ambulatory Care
5.3.7 Y-o-Y Growth Analysis, By End User
5.3.8 Market Attractiveness Analysis, By End User
5.3.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Monitoring Type
220.127.116.11 By End User
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Monitoring Type
188.8.131.52 By End User
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Monitoring Type
22.214.171.124 By End User
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Edwards Lifesciences Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 PULSION Medical Systems SE
8.3 LiDCO Group plc.
8.4 Cheetah Medical Inc.
8.5 Deltex Medical Group plc.
8.6 Hemo Sapiens, Inc.
8.7 ICU Medical, Inc.
8.8 Osypka Medical GmbH
8.9 Schwarzer Cardiotek GmbH
8.10 Tensys Medical, Inc
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures